Medication info

Ranisen Tablet (Ranitidine Hydrochloride)

Prescription medicationExpired
Ingredient · strength
Ranitidine Hydrochloride›Strength being verified
Manufacturer / importer
Person Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 201308716 · Approved 2013.08.07

This product's status changed to Expired on 2023.08.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers and esophagitis); improvement of gastric mucosal lesions; prevention of Mendelson syndrome
Who uses it
Adults · Children
Adult dosage
1. Adults Administer ranitidine 150 mg orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg orally twice daily or 300 mg once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same when used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; for conditions caused by nonsteroidal anti-inflammatory drugs, healing usually occurs within 8 weeks, although the healing period may occasionally be longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medication, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg twice daily for 8 weeks or 300 mg once daily at bedtime. The dose may be increased to 150 mg 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with 150 mg 3 times daily and increase the dose as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Treatment is generally initiated with an injectable formulation. Once oral administration is possible, switch to oral administration and give 150 mg twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 150 mg 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis Administer 150 mg once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the medication; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Children's dosage
For patients 12 years of age and older, administer 75 mg orally twice daily (liquid formulation only). For patients 8 〜 18 years of age, up to 150 mg (2 mg per kg of body weight) may be administered twice daily.

Ingredients

Manufacturer
Person Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers and esophagitis); improvement of gastric mucosal lesions; prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers due to NSAID administration
  • acute gastritis
  • acute exacerbation of chronic gastritis
  • upper gastrointestinal bleeding
  • peptic ulcer
  • acute stress ulcer
  • acute gastric mucosal lesions
View approved original text

This drug is used for gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson's syndrome before anesthesia and is effective in treating postoperative ulcers and preventing ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It improves gastric mucosal lesions during exacerbation of acute and chronic gastritis and helps in treating upper gastrointestinal bleeding due to peptic ulcers or acute stress ulcers. Additionally, it is used to relieve symptoms such as heartburn and acid reflux caused by excessive gastric acid. Overall, this drug is used to improve and treat symptoms of various gastrointestinal disorders.

Dosage and Administration

Adult dosage

1. Adults Administer ranitidine 150 mg orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg orally twice daily or 300 mg once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same when used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; for conditions caused by nonsteroidal anti-inflammatory drugs, healing usually occurs within 8 weeks, although the healing period may occasionally be longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medication, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg twice daily for 8 weeks or 300 mg once daily at bedtime. The dose may be increased to 150 mg 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with 150 mg 3 times daily and increase the dose as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Treatment is generally initiated with an injectable formulation. Once oral administration is possible, switch to oral administration and give 150 mg twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 150 mg 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis Administer 150 mg once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the medication; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.

Children's dosage

For patients 12 years of age and older, administer 75 mg orally twice daily (liquid formulation only). For patients 8 〜 18 years of age, up to 150 mg (2 mg per kg of body weight) may be administered twice daily.

Precautions

This drug should not be used in patients with a history of allergic reactions to any of the components of this drug. It is also safe to avoid in patients with a rare blood disorder called acute porphyria. For patients with impaired kidney function, the dosage should be adjusted by reducing the dose or extending the interval between doses, as this drug can remain in the body for a long time. Caution is also advised in patients with poor liver function. Patients with a history of drug allergic reactions, the elderly, and those taking NSAIDs should exercise special caution. In particular, patients who are experiencing new digestive symptoms or have a history of gastric ulcers and are over middle age should use this drug only after ruling out the possibility of stomach cancer. Patients with gastric or duodenal ulcers associated with Helicobacter pylori should also undergo eradication therapy. While taking this drug, severe allergic reactions such as shock, hives, and difficulty breathing may rarely occur, so if any abnormal symptoms develop, the drug should be discontinued immediately and treatment sought. Blood tests may show decreased white blood cells or platelets; if systemic fatigue, bleeding, or fever occurs, it is important to see a doctor for testing. If symptoms of liver dysfunction or jaundice develop, the drug should be stopped immediately and consultation with a doctor is advised. Patients with a history of heart disease should be cautious, as heart rate may slow or become irregular. Gastrointestinal symptoms such as constipation, nausea, and abdominal pain may also occur. Neurological symptoms such as dizziness, drowsiness, headaches, insomnia, and mental confusion may happen, and if symptoms are severe, discontinuation should be considered. Muscle pain or joint pain may occur, and rare cases of muscle damage have been reported; any unusual symptoms should be communicated to a physician. Skin rashes or hair loss may occur infrequently. During treatment, regular blood tests, liver function tests, and kidney function tests should be conducted, and caution should be exercised as the risk of pneumonia may increase in the elderly or those with chronic illnesses. Patients should avoid driving or operating dangerous machinery if dizziness or drowsiness occur while taking this medication. There may be interactions with other drugs, so it is essential to inform a doctor or pharmacist if other medications are being taken. Particular caution should be observed when taken with anticoagulants or certain heart medications, as monitoring of blood coagulation status is necessary. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of taking this drug, and caution is also recommended for nursing mothers. For children, safety has not been fully established, so use should be cautious. In case of overdose, severe adverse effects are rare, but emergency measures such as vomiting or gastric lavage may be necessary. This drug should be kept out of reach of children and should not be transferred to another container.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine levels
Show 52 more
  • leukopenia
  • thrombocytopenia
  • bone marrow hypocellularity
  • aplastic anemia
  • hypoplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • heart block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distention
  • abdominal pain
  • anorexia
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • seizures
  • headache
  • heaviness in the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disturbances
  • hypertensive muscle cramps
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • stomatitis
  • pruritus
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to light, so it should be stored in a container that blocks light and kept at a temperature between 1 to 30 degrees Celsius. Therefore, it is important to avoid direct sunlight and maintain it in an appropriate temperature environment until it is used.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.